Metabolomics Market | Increased Demand, Current and Future Trends, CAGR of 12.2% (2030)
The metabolomics market is experiencing significant growth, with projections estimating it to reach $6.66 billion by 2030, growing at a CAGR of 12.2%.
The metabolomics market is experiencing significant growth, with projections estimating it to reach $6.66 billion by 2030, growing at a CAGR of 12.2%.
According to the report, the behavioral rehabilitation market was valued at $421.5 billion in 2023, and is estimated to reach $777.2 billion by 2033, growing at a CAGR of 6.
Jeremy Fields, vice president of corporate development at Newsmatics, has been accepted into the Forbes Communications Council, a prestigious, invitation-only organization made up of public relations leaders from across the country.
3Together, Inc., a privately held employee benefits innovation lab, today announced it has become a Workday Partner. The partnership will expand access to SwellSpace, a communication platform that helps employers deliver clear and accessible HR and benefits information to employees, dependents, and candidates.
According to a new report, According to a new report, "Australia Period Care Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product Type, Distribution Channel : Opportunity Analysis and Industry Forecast, 2021-2030".
Blood Pressure Monitoring Devices: Market Overview, Key Segments The global blood pressure monitoring devices market is experiencing strong growth, driven by the rising prevalence of hypertension and cardiovascular diseases, growing awareness about preventive healthcare, and increasing adoption of home healthcare technologies.
ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation, and CellReady, today announced that Xellera Therapeutics has been awarded a US$150,000 G-Rex® Grant to support the establishment of a highly efficient cGMP G-Rex® centric NK cell manufacturing platform NK cell therapies represent a rapidly growing segment in immuno-oncology, offering off-the-shelf treatment options for a wide range of solid tumors, hematologic malignancies, and viral infections.